Advertisement
Product › Details
drug development technology_o
Next higher product group | drug development technology | |
Record changed: 2023-07-10 |
Advertisement
More documents for drug development technology_o
- [1] Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA....
- [2] Mirador Therapeutics, Inc.. (3/21/24). "Press Release: Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases". San Diego, CA....
- [3] SpliceBio S.L.. (10/17/23). "Press Release: SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease". Barcelona....
- [4] Ariceum Therapeutics GmbH. (5/11/23). "Press Release: UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer". Berlin & Brussels....
- [5] Neogap Therapeutics AB. (5/4/23). "Press Release: Neogap and Cellerys Enter Collaboration Related to Phase II Study of a New Therapy for Multiple Sclerosis"....
- [6] APIS Assay Technologies Ltd.. (2/2/23). "Press Release: Clickmer Systems Receives €1.1m Grant to Deliver Innovative Diagnostic Platform for Fast Pandemic Responsiveness"....
- [7] Elsamogen Ltd.. (5/18/22). "Press Release: BGF, Scottish National Investment Bank and Scottish Enterprise Join Forces to Invest £8m in Aberdeen Biologics Company Elasmogen". Aberdeen....
- [8] University of Bonn. (4/25/22). "Press Release: Successful Spin-off from the University of Bonn and LS. APIS Assay Technologies Ltd Acquires Startup Clickmer Systems"....
- [9] SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona....
- [10] GlycoEra AG. (11/5/21). "Press Release: GlycoEra AG Raises CHF 45 Million (US$ 49 Million) Series A Financing to Develop Novel Biologics Based on Innovative Glycoengineering Platform". Schlieren....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top